SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: William Strop who wrote (295)7/31/1997 12:32:00 AM
From: Rainforest   of 1972
 
It's probably just a depressed biotech sector. Take a look at the other stocks that Michael Murphy in his California Technology Stock Letter
has targeted for a share price of $100 or more by 97-99. The "paid" price is the price as of 2/97:

SYMBOL 7/30/97 PRICE 2/97 PRICE GAIN/LOSS %
AMLN 13 1/16 14 1/2 -9.91
ARRS 11 3/4 14 1/2 -18.97
HGSI 33 37 1/2 -12.00
ISIP 13 1/4 18 7/8 -29.80
LGND 13 1/4 12 1/8 +9.28
RZYM 8 1/4 11 7/8 -30.53
SQNA 9 3/4 15 1/8 -35.54
SUGN 13 1/2 12 7/8 +4.85
VICL 11 1/8 17 -34.56

On the other hand, it could be market makers shaking out the deadwood in anticipation of a collaboration or merger that could goose the price.

I have a hunch it's the latter, but that may be wishful thinking. In any event, VICL is worth a lot more than $11. I wish I had the bucks to average down here.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext